Thailand reported a total of 22,197 daily Covid-19 infections with 45 additional deaths in the past 24 hours, the Center for Covid-19 Situation Administration (CCSA) reported today, March 2nd.
The fatalities were 28 men and 17 women with the highest deaths recorded in Phuket with 4. All of them were Thai nationals. The age range was between 28 and 98 years old.
Most of them were reported with underlying health conditions, including cancer (2), obesity (1), and kidney disease (16). Three of the fatalities was bedridden patients and two were reportedly deceased at home.
Of the new cases, 21,610 were found in hospitals and medical services (which includes contact tracing cases), 248 were from a proactive approach at previously reported clusters, 221 were from prisons, and the remaining 118 were imported cases.
A number of 218,784 patients are still under treatment/isolation/medical care. Of that, 1,094 patients are in critical condition including 310 on ventilators. This is roughly 0.50 percent of cases that are critical while 28.3 percent of that is critical enough for a ventilator.
Regarding the non-prison local infections, the highest number of patients were reported in Bangkok with 3,018, followed by Chonburi with 1,134, Samut Prakan with 986, Phuket with 688, Nonthaburi with 682, and Samut Sakhon with 678.
A total number of 226,694 people nationwide have received Covid-19 vaccines in the past 24 hours. Of that, 79,567 people had received their first shots, 31,045 people had received their second shots, and 116,082 people had received their third shots. This is roughly 77.1% of the total Thai population who have had their first shot of a Covid-19 vaccine, 71.6% who have had a second shot and are fully vaccinated, and 29.6% have had a third booster shot.
As of today, 19,093 people fully recovered in the past 24 hours and have been released from field hospitals and quarantine centers. Thailand has now reached a total of 2,934,544 cases with 2,692,739 recoveries and a total of 23,021 deaths since the start of the pandemic.
Follow us on Facebook